Product Name :
PDHK-IN-4
CAS No.:
Purity :
> 98%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
Product Description :
PDHK-IN-4 (Compound 30) is a potent inhibitor of PDHK with IC50s of 0.0051 and 0.0122 μM for PDHK2 and PDHK4, repectively. Pyruvate dehydrogenase kinases (PDHKs) are fascinating drug targets for numerous diseases, including diabetes and cancers. PDHK-IN-4 has the potential for the research of cancer diseases.{{Bezlotoxumab} medchemexpress|{Bezlotoxumab} Bacterial|{Bezlotoxumab} Technical Information|{Bezlotoxumab} Purity|{Bezlotoxumab} custom synthesis|{Bezlotoxumab} Cancer}
Formula:
C24H25N5O3
Molecular Weight :
431.{{D(+)-Galactosamine} MedChemExpress|{D(+)-Galactosamine} Biological Activity|{D(+)-Galactosamine} In Vitro|{D(+)-Galactosamine} custom synthesis|{D(+)-Galactosamine} Autophagy} 49
Synonyms:
Additional Information:
|Formula C24H25N5O3 ; |Molecular Weight 431.49 ; |Product Description PDHK-IN-4 (Compound 30) is a potent inhibitor of PDHK with IC50s of 0.PMID:24406011 0051 and 0.0122 μM for PDHK2 and PDHK4, repectively. Pyruvate dehydrogenase kinases (PDHKs) are fascinating drug targets for numerous diseases, including diabetes and cancers. PDHK-IN-4 has the potential for the research of cancer diseases. ; |Format Solid ; |Purity > 98% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO